SlideShare a Scribd company logo
1 of 33
Download to read offline
HEMATOLOGY COURSE
Introduction
2nd
23th feb.2017
1WaseemTameemi
Learning objectives
 ✓ Recognize the different types of leucocytes
(myeloid cells & lympoid cells).
 ✓ List the normal values for neutrophils,
eosinophils, basophils, and monocytes in
normal peripheral blood
 ✓ Be familiar with terms of leukoerythroblastic
picture and leukemoid reaction
 ✓ Identify conditions that cause increase or
decrease for each of them.
2WaseemTameemi
The white blood cells
(leucocytes):
 Phagocytes
 innate immune system,
1. Granulocytes: (neutrophils,
eosinophils , basophils) and
2. monocytes
 Lymphocytes
 adaptive immune response,
WaseemTameemi 3
Leucocyte
 Mediate host defense
 Modulate the immune response
 The relative proportion
 The absolute number
 ―ANC‖—absolute neutrophil count
 – Philia, – cytosis
 – Penia
WaseemTameemi 4
WaseemTameemi 5
Leukocytes: White Blood Cells
Involved in
fighting infection,
combating allergic
reactions, and
immune
responses.
6WaseemTameemi
myeloblast
neutrophil
promyelocyte myelocyte
Band formmetamyelocyte
eosinophil
basophil
The first recognizable granulocyte in the marrow is the myeloblast
7WaseemTameemi
Neutrophils
 maturation within 5 days in BM
 stay 6-10 hours in the circulation
before being removed, mainly by
the spleen.
 Myeloblast, promyelocyte,
Myelocytes or metamyelocytes are
normally only found in the marrow
 if appear in the circulation :
 infection or neoplastic states or
BM stimulation.
WaseemTameemi 8
Left shift WBC
9WaseemTameemi
Clinical applications of
G‐CSF
1. Neutropenia :
A. Post‐chemotherapy,
B. Post-radiotherapy
C. stem cell transplantation (SCT)
2. Severe benign neutropenia :
 congenital cyclic neutropeniaand
 acquired neutropenia
3. Myelodysplasia and aplastic anaemia.
4. Peripheral blood stem cell
mobilization.
WaseemTameemi 10
Leukoerythroblastic reaction
WaseemTameemi 11
The abnormal appearance of immature
precursors of both cell lines
in the peripheral blood
Leukoerythroblastic reaction
 a serious disturbance of marrow function
 The WBC count may be increased,
normal, or decreased
 BM metastasis
 MF
 Leukemia (AML,CML)
 MM
 Reactive states ( hemorrhage or hemolysis )
 Corticosteroid therapy
 Indication of bone marrow study
WaseemTameemi 12
Neutrophils
 the most common white
blood cells in the blood
of adults.
 approximately 65 %
 2-5 segments nuclei
and granules in their
cytoplasm.
13WaseemTameemi
 Phagocytizing
offending organisms
 releasing toxic
oxygen
 antimicrobial
proteins
WaseemTameemi 14
Neutrophilic leukocytosis
 total WBC >>11,000/mm³
(11 X109/L )
 absolute neutrophil count (ANC) of
more than 7500/mm³(7.5 × 109/L)
 more than 70% neutrophils
 Granulocytosis = neutrophilia
15WaseemTameemi
Neutrophilic leukocytosis
 Physiological
 Smoking
 Acute Infection
(bacterial ,fungal)
 Inflammation
 Necrosis
 Acute hemoarrhge
or hemolysis
 Metabolic
 Malignancy
 Drugs
(Glucocorticoids
,tetracycline,
epinephrine
,Lithium , G-CSF )
 Heatstroke
 Down syndrome
16WaseemTameemi
Leukemoid reaction
WaseemTameemi 17
 Excessiv reactive leukocytosis
 30,000- 50,000/mm³ (30-50 x109/L(
Leukemoid reaction
 Benign leukocytic proliferation
 a significant increase in immature
precursors in the peripheral blood
(myeloblast, myelocytes,
metamyelocytes, band) along with
increased numbers of mature forms.
 DDX: acute or chronic leukemia
 Severe infection, metastatic cancer,
hemolysis, burn.
WaseemTameemi 18
Eosinophils
 represent 1-6% of
the circulating WBC.
 involved in
 intracellular killing of
protozoa and
helminths
 allergic reactions
(e.g. atopy, asthma)
19WaseemTameemi
Eosinophilic leukocytosis
 >> 500/mm³ (0.5x109/L )
 Allergy,hay fever, eczema,
asthma
 Parasitic infection
 Skin diseases
 Drug hypersensitivity ; sulpha,
gold
 Vasculitis:Churg Strauss
disease.
 Loffler’s syndrome
 Malignancy; lymphoma ,HES,
AML,CML
20WaseemTameemi
Hypereosinophilic syndrome
HES
eosinophil count is elevated
(above 1.5 × 109/L) for over 6
months and associated with
tissue damage
WaseemTameemi 21
Basophils
 Less than 1% of WBC.
 Mast cells resemble
basophils (only found
in the tissues).
 They release histamine
 type I hypersensitivity
reaction and
 defense against parasites
22WaseemTameemi
basophilic leukocytosis
 >> 100/mm³ (0.1 X109/L) .
 Causes:
 Viral infection: chicken pox
 Myeloproliferative disorders,
chronic myeloid leukemia ,
PRV, mastocytosis.
 Hypersensitivity reactions
 Inflammation (IBD)
 Hypothyroidism
 Post splenectomy
23WaseemTameemi
Monocytes
WaseemTameemi 24
 2 to 10% of circulating WBCs.
Monocytes
 Main functions of macrophages:
1) Phagocytosis.
2) Facilitate wound healing.
3) Removal of senescent RBCs in
reticuloendothelial system
(spleen, liver and bone marrow).
4) Presentation of antigen to T
lymphocytes.
WaseemTameemi 25
Monocytic leukocytosis
 >> 800/mm³.
 tuberculosis,
brucella, malaria
 recovery stage of
chronic infections,
 CTD
 MDS, AML, solid
tumors, Hodgkin
lymphoma
26WaseemTameemi
Lymphocytes
 T cells (80% of circulating
lymphoid cells)
 B cells
expression of immunoglobulin
light chains
 lifespan can vary from several
days to many years.
27WaseemTameemi
Lymphocytic leukocytosis
 >> 3,500/mm³
( 3.5 X109/L )
 infections such as viral;
(infectious mononucleosis
,mumps , measles) and
bacterial; (pertussis, TB)
 lymphoproliferative disorders:
acute and chronic lymphocytic
leukemias, lymphoma
 post splenectomy
28WaseemTameemi
Neutropenia
 < 1500/mm³. (1.5 X109/L)
 < 500/mm³ (0.5 X109/L)
 Agranulocytosis : neutropenia
 recurrent infections
 Bone marrow examination
 less than 0.2 × 109/L
 very serious
 Very significant risk of infection; fever should
always be managed on an inpatient basis with
parenteral antibiotics; few or no clinical signs of
infection
29WaseemTameemi
The clinical features of
neutropenia:
 risk of infection, at the mouth and
throat.
 Painful necrotizing ulcers on oral
cavity , the anus and skin (boil,
abscess)
 The general symptoms :fever, chills,
malaise, weakness and fatigability.
 Septicaemia
 the infection will be severe & life threatening
within hours to few days
30WaseemTameemi
The clinical features of
neutropenia:
 Commensal by normal
individuals may become
pathogens.
 (Staphylococcus epidermidis or
Gram‐negative organisms in the bowel)
 Candida and Aspergillus.
 Invasive bacterial or fungal infections
may occur in the organs like GIT, lungs
and urinary tract.
31WaseemTameemi
Neutropenia
1. infections:
 Flu,Hepatitis B virus, Epstein-Barr virus and
HIV
 Enteric fever, brucellosis, and tuberculosis
 Malaria
2. Drugs: cytotoxic, carbimazole, sulphasalazine,
trimethoprim, carbamazapines,
3. Auto immune:SLE, Felty’s syndrome
4. Congenital: Kostmann’s syndrome,
Schwachman–Diamond
5. acute leukemia
6. bone marrow failure or infiltration
32WaseemTameemi
Lymphopenia
 < 1000 /mm³ (1 X109/L).
 CTD, Renal failure, sarcoidiosis,
 steroid & radiation
 Hodgkin
 congenital severe Combined
Immune Deficiency
33WaseemTameemi

More Related Content

What's hot

Acute myelogenous leukemia (aml)
Acute myelogenous leukemia (aml)Acute myelogenous leukemia (aml)
Acute myelogenous leukemia (aml)
John Velo
 
Ascp under the_microscope_101
Ascp under the_microscope_101Ascp under the_microscope_101
Ascp under the_microscope_101
cbrownwhs
 
Hematopoiesis 06 07
Hematopoiesis 06 07Hematopoiesis 06 07
Hematopoiesis 06 07
raj kumar
 
White Blood Cell
White Blood CellWhite Blood Cell
White Blood Cell
Bong Tong
 
Wbcs
WbcsWbcs
Wbcs
IIDC
 
Wbc structure and functions
Wbc structure and functionsWbc structure and functions
Wbc structure and functions
Akila S.Akila
 

What's hot (20)

White blood cells / Leucocytes
White blood cells / LeucocytesWhite blood cells / Leucocytes
White blood cells / Leucocytes
 
Chronic leukemia
  Chronic leukemia    Chronic leukemia
Chronic leukemia
 
Haematological test by ameena begam
Haematological test by ameena begamHaematological test by ameena begam
Haematological test by ameena begam
 
POWERPOINT PRESENTATION ON WHITE BLOOD CELLS
POWERPOINT PRESENTATION ON WHITE BLOOD CELLSPOWERPOINT PRESENTATION ON WHITE BLOOD CELLS
POWERPOINT PRESENTATION ON WHITE BLOOD CELLS
 
Hematopoiesis
HematopoiesisHematopoiesis
Hematopoiesis
 
Acute myelogenous leukemia (aml)
Acute myelogenous leukemia (aml)Acute myelogenous leukemia (aml)
Acute myelogenous leukemia (aml)
 
PERICARDIAL FLUID
PERICARDIAL FLUIDPERICARDIAL FLUID
PERICARDIAL FLUID
 
Leukopiesis and agranulositosis 2011
Leukopiesis and agranulositosis 2011Leukopiesis and agranulositosis 2011
Leukopiesis and agranulositosis 2011
 
Group 2 ak
Group  2 akGroup  2 ak
Group 2 ak
 
Ascp under the_microscope_101
Ascp under the_microscope_101Ascp under the_microscope_101
Ascp under the_microscope_101
 
Leucocytes
LeucocytesLeucocytes
Leucocytes
 
Hematopoiesis 06 07
Hematopoiesis 06 07Hematopoiesis 06 07
Hematopoiesis 06 07
 
Differential leukocyte count
Differential leukocyte countDifferential leukocyte count
Differential leukocyte count
 
MA119 Chapter 48 analysis of blood
MA119 Chapter 48 analysis of bloodMA119 Chapter 48 analysis of blood
MA119 Chapter 48 analysis of blood
 
Wbc
WbcWbc
Wbc
 
White Blood Cell
White Blood CellWhite Blood Cell
White Blood Cell
 
Wbcs
WbcsWbcs
Wbcs
 
Benign White blood cell (WBC) Disorders
Benign White blood cell (WBC) DisordersBenign White blood cell (WBC) Disorders
Benign White blood cell (WBC) Disorders
 
Leukopoieses
LeukopoiesesLeukopoieses
Leukopoieses
 
Wbc structure and functions
Wbc structure and functionsWbc structure and functions
Wbc structure and functions
 

Similar to L2 introduction wbc2017 student

White Blood Cell Disorders (ramkumaradhikari)
White Blood Cell Disorders (ramkumaradhikari)White Blood Cell Disorders (ramkumaradhikari)
White Blood Cell Disorders (ramkumaradhikari)
Ramkumar Adhikari
 
medicine.Acute leukemias.(dr.sabir)
medicine.Acute leukemias.(dr.sabir)medicine.Acute leukemias.(dr.sabir)
medicine.Acute leukemias.(dr.sabir)
student
 
10 OVERVIEW OF WHITE BLOOD CE111111111LLS.ppt
10 OVERVIEW OF WHITE BLOOD CE111111111LLS.ppt10 OVERVIEW OF WHITE BLOOD CE111111111LLS.ppt
10 OVERVIEW OF WHITE BLOOD CE111111111LLS.ppt
marrahmohamed33
 
Physio blood physiology
Physio blood physiologyPhysio blood physiology
Physio blood physiology
Ghaidaa Sadeq
 
E-2. ÀÌÁ¤³à_Atlas of lymphocyte.pdf
E-2. ÀÌÁ¤³à_Atlas of lymphocyte.pdfE-2. ÀÌÁ¤³à_Atlas of lymphocyte.pdf
E-2. ÀÌÁ¤³à_Atlas of lymphocyte.pdf
Aditya Sinha
 
Acute Myeloid Leukemia
Acute Myeloid LeukemiaAcute Myeloid Leukemia
Acute Myeloid Leukemia
Ali Swailmeen
 
R PPT to Present-1ddddddddddddddddddddd.pptx
R PPT to Present-1ddddddddddddddddddddd.pptxR PPT to Present-1ddddddddddddddddddddd.pptx
R PPT to Present-1ddddddddddddddddddddd.pptx
dmfrmicro
 

Similar to L2 introduction wbc2017 student (20)

Acute leukaemia
Acute leukaemia Acute leukaemia
Acute leukaemia
 
Leukemia
Leukemia Leukemia
Leukemia
 
Lab investigations in OMFS- ih
Lab investigations in OMFS- ihLab investigations in OMFS- ih
Lab investigations in OMFS- ih
 
White Blood Cell Disorders (ramkumaradhikari)
White Blood Cell Disorders (ramkumaradhikari)White Blood Cell Disorders (ramkumaradhikari)
White Blood Cell Disorders (ramkumaradhikari)
 
Chronic Lymphocytic Leukemia
Chronic Lymphocytic LeukemiaChronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
 
medicine.Acute leukemias.(dr.sabir)
medicine.Acute leukemias.(dr.sabir)medicine.Acute leukemias.(dr.sabir)
medicine.Acute leukemias.(dr.sabir)
 
Leukemia
LeukemiaLeukemia
Leukemia
 
AML ALL HL NHL.pptx
AML ALL HL NHL.pptxAML ALL HL NHL.pptx
AML ALL HL NHL.pptx
 
Noon Conference
Noon Conference Noon Conference
Noon Conference
 
Abnormalities of WBC
Abnormalities of WBCAbnormalities of WBC
Abnormalities of WBC
 
10 OVERVIEW OF WHITE BLOOD CE111111111LLS.ppt
10 OVERVIEW OF WHITE BLOOD CE111111111LLS.ppt10 OVERVIEW OF WHITE BLOOD CE111111111LLS.ppt
10 OVERVIEW OF WHITE BLOOD CE111111111LLS.ppt
 
Leukemia and its types presentation 1
Leukemia and its types presentation 1Leukemia and its types presentation 1
Leukemia and its types presentation 1
 
Leukemia.pptx
Leukemia.pptxLeukemia.pptx
Leukemia.pptx
 
LEUKEMIA.pptx
LEUKEMIA.pptxLEUKEMIA.pptx
LEUKEMIA.pptx
 
All ACUTE LYMPHOBLASTIC LEUKEMIA BY DR MAGDI SASI
All ACUTE LYMPHOBLASTIC LEUKEMIA  BY DR MAGDI SASIAll ACUTE LYMPHOBLASTIC LEUKEMIA  BY DR MAGDI SASI
All ACUTE LYMPHOBLASTIC LEUKEMIA BY DR MAGDI SASI
 
Physio blood physiology
Physio blood physiologyPhysio blood physiology
Physio blood physiology
 
E-2. ÀÌÁ¤³à_Atlas of lymphocyte.pdf
E-2. ÀÌÁ¤³à_Atlas of lymphocyte.pdfE-2. ÀÌÁ¤³à_Atlas of lymphocyte.pdf
E-2. ÀÌÁ¤³à_Atlas of lymphocyte.pdf
 
Acute Myeloid Leukemia
Acute Myeloid LeukemiaAcute Myeloid Leukemia
Acute Myeloid Leukemia
 
Leukocytosis
LeukocytosisLeukocytosis
Leukocytosis
 
R PPT to Present-1ddddddddddddddddddddd.pptx
R PPT to Present-1ddddddddddddddddddddd.pptxR PPT to Present-1ddddddddddddddddddddd.pptx
R PPT to Present-1ddddddddddddddddddddd.pptx
 

Recently uploaded

Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartCardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
MedicoseAcademics
 
Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulation
MedicoseAcademics
 

Recently uploaded (20)

Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
 
Anuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatmentAnuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatment
 
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptxThe Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
 
Denture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDenture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of action
 
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAntiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
 
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxIs Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
 
TUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHY
TUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHYTUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHY
TUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHY
 
180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana
 
CT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic traumaCT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic trauma
 
Why invest into infodemic management in health emergencies
Why invest into infodemic management in health emergenciesWhy invest into infodemic management in health emergencies
Why invest into infodemic management in health emergencies
 
Introducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionIntroducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European Union
 
Creating Accessible Public Health Communications
Creating Accessible Public Health CommunicationsCreating Accessible Public Health Communications
Creating Accessible Public Health Communications
 
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
 
linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...
 
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadHemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
 
Compare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from homeCompare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from home
 
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartCardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
 
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerCas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
 
Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulation
 
Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...
 

L2 introduction wbc2017 student

  • 2. Learning objectives  ✓ Recognize the different types of leucocytes (myeloid cells & lympoid cells).  ✓ List the normal values for neutrophils, eosinophils, basophils, and monocytes in normal peripheral blood  ✓ Be familiar with terms of leukoerythroblastic picture and leukemoid reaction  ✓ Identify conditions that cause increase or decrease for each of them. 2WaseemTameemi
  • 3. The white blood cells (leucocytes):  Phagocytes  innate immune system, 1. Granulocytes: (neutrophils, eosinophils , basophils) and 2. monocytes  Lymphocytes  adaptive immune response, WaseemTameemi 3
  • 4. Leucocyte  Mediate host defense  Modulate the immune response  The relative proportion  The absolute number  ―ANC‖—absolute neutrophil count  – Philia, – cytosis  – Penia WaseemTameemi 4
  • 6. Leukocytes: White Blood Cells Involved in fighting infection, combating allergic reactions, and immune responses. 6WaseemTameemi
  • 7. myeloblast neutrophil promyelocyte myelocyte Band formmetamyelocyte eosinophil basophil The first recognizable granulocyte in the marrow is the myeloblast 7WaseemTameemi
  • 8. Neutrophils  maturation within 5 days in BM  stay 6-10 hours in the circulation before being removed, mainly by the spleen.  Myeloblast, promyelocyte, Myelocytes or metamyelocytes are normally only found in the marrow  if appear in the circulation :  infection or neoplastic states or BM stimulation. WaseemTameemi 8
  • 10. Clinical applications of G‐CSF 1. Neutropenia : A. Post‐chemotherapy, B. Post-radiotherapy C. stem cell transplantation (SCT) 2. Severe benign neutropenia :  congenital cyclic neutropeniaand  acquired neutropenia 3. Myelodysplasia and aplastic anaemia. 4. Peripheral blood stem cell mobilization. WaseemTameemi 10
  • 11. Leukoerythroblastic reaction WaseemTameemi 11 The abnormal appearance of immature precursors of both cell lines in the peripheral blood
  • 12. Leukoerythroblastic reaction  a serious disturbance of marrow function  The WBC count may be increased, normal, or decreased  BM metastasis  MF  Leukemia (AML,CML)  MM  Reactive states ( hemorrhage or hemolysis )  Corticosteroid therapy  Indication of bone marrow study WaseemTameemi 12
  • 13. Neutrophils  the most common white blood cells in the blood of adults.  approximately 65 %  2-5 segments nuclei and granules in their cytoplasm. 13WaseemTameemi
  • 14.  Phagocytizing offending organisms  releasing toxic oxygen  antimicrobial proteins WaseemTameemi 14
  • 15. Neutrophilic leukocytosis  total WBC >>11,000/mm³ (11 X109/L )  absolute neutrophil count (ANC) of more than 7500/mm³(7.5 × 109/L)  more than 70% neutrophils  Granulocytosis = neutrophilia 15WaseemTameemi
  • 16. Neutrophilic leukocytosis  Physiological  Smoking  Acute Infection (bacterial ,fungal)  Inflammation  Necrosis  Acute hemoarrhge or hemolysis  Metabolic  Malignancy  Drugs (Glucocorticoids ,tetracycline, epinephrine ,Lithium , G-CSF )  Heatstroke  Down syndrome 16WaseemTameemi
  • 17. Leukemoid reaction WaseemTameemi 17  Excessiv reactive leukocytosis  30,000- 50,000/mm³ (30-50 x109/L(
  • 18. Leukemoid reaction  Benign leukocytic proliferation  a significant increase in immature precursors in the peripheral blood (myeloblast, myelocytes, metamyelocytes, band) along with increased numbers of mature forms.  DDX: acute or chronic leukemia  Severe infection, metastatic cancer, hemolysis, burn. WaseemTameemi 18
  • 19. Eosinophils  represent 1-6% of the circulating WBC.  involved in  intracellular killing of protozoa and helminths  allergic reactions (e.g. atopy, asthma) 19WaseemTameemi
  • 20. Eosinophilic leukocytosis  >> 500/mm³ (0.5x109/L )  Allergy,hay fever, eczema, asthma  Parasitic infection  Skin diseases  Drug hypersensitivity ; sulpha, gold  Vasculitis:Churg Strauss disease.  Loffler’s syndrome  Malignancy; lymphoma ,HES, AML,CML 20WaseemTameemi
  • 21. Hypereosinophilic syndrome HES eosinophil count is elevated (above 1.5 × 109/L) for over 6 months and associated with tissue damage WaseemTameemi 21
  • 22. Basophils  Less than 1% of WBC.  Mast cells resemble basophils (only found in the tissues).  They release histamine  type I hypersensitivity reaction and  defense against parasites 22WaseemTameemi
  • 23. basophilic leukocytosis  >> 100/mm³ (0.1 X109/L) .  Causes:  Viral infection: chicken pox  Myeloproliferative disorders, chronic myeloid leukemia , PRV, mastocytosis.  Hypersensitivity reactions  Inflammation (IBD)  Hypothyroidism  Post splenectomy 23WaseemTameemi
  • 24. Monocytes WaseemTameemi 24  2 to 10% of circulating WBCs.
  • 25. Monocytes  Main functions of macrophages: 1) Phagocytosis. 2) Facilitate wound healing. 3) Removal of senescent RBCs in reticuloendothelial system (spleen, liver and bone marrow). 4) Presentation of antigen to T lymphocytes. WaseemTameemi 25
  • 26. Monocytic leukocytosis  >> 800/mm³.  tuberculosis, brucella, malaria  recovery stage of chronic infections,  CTD  MDS, AML, solid tumors, Hodgkin lymphoma 26WaseemTameemi
  • 27. Lymphocytes  T cells (80% of circulating lymphoid cells)  B cells expression of immunoglobulin light chains  lifespan can vary from several days to many years. 27WaseemTameemi
  • 28. Lymphocytic leukocytosis  >> 3,500/mm³ ( 3.5 X109/L )  infections such as viral; (infectious mononucleosis ,mumps , measles) and bacterial; (pertussis, TB)  lymphoproliferative disorders: acute and chronic lymphocytic leukemias, lymphoma  post splenectomy 28WaseemTameemi
  • 29. Neutropenia  < 1500/mm³. (1.5 X109/L)  < 500/mm³ (0.5 X109/L)  Agranulocytosis : neutropenia  recurrent infections  Bone marrow examination  less than 0.2 × 109/L  very serious  Very significant risk of infection; fever should always be managed on an inpatient basis with parenteral antibiotics; few or no clinical signs of infection 29WaseemTameemi
  • 30. The clinical features of neutropenia:  risk of infection, at the mouth and throat.  Painful necrotizing ulcers on oral cavity , the anus and skin (boil, abscess)  The general symptoms :fever, chills, malaise, weakness and fatigability.  Septicaemia  the infection will be severe & life threatening within hours to few days 30WaseemTameemi
  • 31. The clinical features of neutropenia:  Commensal by normal individuals may become pathogens.  (Staphylococcus epidermidis or Gram‐negative organisms in the bowel)  Candida and Aspergillus.  Invasive bacterial or fungal infections may occur in the organs like GIT, lungs and urinary tract. 31WaseemTameemi
  • 32. Neutropenia 1. infections:  Flu,Hepatitis B virus, Epstein-Barr virus and HIV  Enteric fever, brucellosis, and tuberculosis  Malaria 2. Drugs: cytotoxic, carbimazole, sulphasalazine, trimethoprim, carbamazapines, 3. Auto immune:SLE, Felty’s syndrome 4. Congenital: Kostmann’s syndrome, Schwachman–Diamond 5. acute leukemia 6. bone marrow failure or infiltration 32WaseemTameemi
  • 33. Lymphopenia  < 1000 /mm³ (1 X109/L).  CTD, Renal failure, sarcoidiosis,  steroid & radiation  Hodgkin  congenital severe Combined Immune Deficiency 33WaseemTameemi